Ref. AU 009/2017 - Translation - 15 May 2017 To: Director and the President The Stock Exchange of Thailand Management Discussion and Analysis for the three-month period ended 31 March 2017 After You
Ref. AU 011/2017 - Translation - 11 August 2017 To: Director and the President The Stock Exchange of Thailand Management Discussion and Analysis for the six-month period ended 30 June 2017 After You
-1- AIT (VP-SEC) 012E/2021 May 6, 2021 Subject: Management's Discussion and Analysis of Operating Results for Q1-2021 To: The President of the Stock Exchange of Thailand Summary of Operations Q1–2021
%) 5.31 0.05% 4.29 0.04% (1.02) (19.20%) Total revenues 3,590.56 100.00% 3,587.58 100.00% (2.98) (0.08%) 11,264.47 100.00% 10,340.77 100.00% (923.69) (8.20%) Distribution costs 184.53 5.14% 159.17 4.44
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited
, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like
. 1 Tambon Tarsit, Amohoe Pluag-daeng, Rayong (Translation) 1 KWM 007/2562 May 14th, 2019 Subject : Management Discussion and Analysis the three month-period ended March 31, 2019 To : President The
-Translation- No. ECF2 031/2019 August 14, 2019 Subject: Management Discussion and Analysis of the 2nd quarter ended June 30, 2019 To President The Stock Exchange of Thailand East Coast Furnitech